- Home
- NERV vs CSCI Comparison
NERV vs CSCI Comparison
Compare NERV & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- CSCI
- Stock Information
- Founded
- NERV 2007
- CSCI 1990
- Country
- NERV United States
- CSCI Canada
- Employees
- NERV N/A
- CSCI N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- NERV Health Care
- CSCI
- Exchange
- NERV Nasdaq
- CSCI NYSE
- Market Cap
- NERV 12.6M
- CSCI 10.5M
- IPO Year
- NERV 2014
- CSCI 1996
- Fundamental
- Price
- NERV $1.77
- CSCI $3.37
- Analyst Decision
- NERV Hold
- CSCI
- Analyst Count
- NERV 1
- CSCI 0
- Target Price
- NERV $5.00
- CSCI N/A
- AVG Volume (30 Days)
- NERV 12.2K
- CSCI 2.1K
- Earning Date
- NERV 08-05-2025
- CSCI 08-12-2025
- Dividend Yield
- NERV N/A
- CSCI N/A
- EPS Growth
- NERV N/A
- CSCI N/A
- EPS
- NERV 0.83
- CSCI N/A
- Revenue
- NERV N/A
- CSCI $9,030,000.00
- Revenue This Year
- NERV N/A
- CSCI N/A
- Revenue Next Year
- NERV N/A
- CSCI N/A
- P/E Ratio
- NERV $2.18
- CSCI N/A
- Revenue Growth
- NERV N/A
- CSCI 36.51
- 52 Week Low
- NERV $1.15
- CSCI $1.96
- 52 Week High
- NERV $3.50
- CSCI $7.54
- Technical
- Relative Strength Index (RSI)
- NERV 57.10
- CSCI N/A
- Support Level
- NERV $1.62
- CSCI N/A
- Resistance Level
- NERV $1.83
- CSCI N/A
- Average True Range (ATR)
- NERV 0.09
- CSCI 0.00
- MACD
- NERV -0.00
- CSCI 0.00
- Stochastic Oscillator
- NERV 64.29
- CSCI 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.